Career Enhancement Program

职业提升计划

基本信息

批准号：
10415973
负责人：
Scott Kopetz
金额：
$ 15.27万
依托单位：
UNIVERSITY OF TX MD ANDERSON CAN CTR
依托单位国家：
美国
项目类别：
财政年份：
2019
资助国家：
美国
起止时间：
2019-08-20 至 2024-05-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/10415973
关键词：
Academic Training American Association of Cancer Research American Society of Clinical Oncology Area Award Basic Science Budgets Caliber Cancer Biology Cancer Center Clinical Clinical Trials Clinical trial protocol document Colorectal Cancer Country Development Development Plans Diagnosis Disease Early Diagnosis Ensure Feedback Fellowship Financial Support Funding Goals Grant Individual Institutes Institution International Journals Knowledge Laboratories Laboratory Research Lead Leadership Malignant neoplasm of gastrointestinal tract Malignant neoplasm of pancreas Manuscripts Mentors Mentorship Minority Women Morbidity - disease rate Nature Oncology Pathology Patients Peer Review Physicians Prevention Process Publications Publishing Quality of life Research Research Personnel Research Project Grants Scientist Site Survivors Training Training Programs Translating Translational Research Underrepresented Populations Universities University of Texas M D Anderson Cancer Center Woman Writing anticancer research base cancer diagnosis career career development clinical care design flexibility gastrointestinal improved innovation interest meetings member mortality next generation programs recruit symposium training opportunity translational approach translational potential translational research program translational scientist

项目摘要

CAREER ENHANCEMENT PROGRAM: Summary/Abstract The goal of the Career Enhancement Program (CEP) is to develop highly trained, exceptional young investigators dedicated to translational research in the early detection, prevention, and treatment of pancreatic cancer (PDAC) and colorectal cancer (CRC). Ideally, these investigators will ultimately help to reduce the morbidity and mortality from these diseases. The CEP will extend be available across both participating institutions –MD Anderson and Johns Hopkins University, broadening the scope of expertise and mentorship opportunities available to early career investigators. Underscoring the shared nature of our program, the CEP will be led by Drs. Elizabeth Jaffee at Johns Hopkins and Dr, Scott Kopetz at MD Anderson, respectively. The CEP will A) recruit and train physicians and basic scientists to enable them to become highly skilled translational investigators in the field of PDAC or CRC B) provide specific knowledge of research in PDAC or CRC that will enhance the ability of awardees to conduct innovative translational science that will directly impact on the understanding and treatment of these diseases; and 3) re-direct individuals who have already shown considerable scientific promise into PDAC or CRC research. To achieve this goal, the SPORE CEP will provide up to five awards of $50,000 each annually for one year, with a competitive option for renewal for an additional year, funded from the SPORE and matching funds from MD Anderson and Johns Hopkins. We will aggressively recruit the most promising young investigators and institute an individualized development plan with clinical and laboratory mentors and a mentoring committee that will provide coaching in grant and manuscript writing, leadership training, networking with PDAC and CRC scholars (including key opinion leaders in concurrently funded SPORE programs around the country), and completing and publishing translational PDAC or CRC related manuscripts in high impact peer reviewed journals. The GI SPORE will utilize multiple programs inside and outside of the Institute to identify outstanding young investigators with an emphasis placed on recruiting qualified women and members of traditionally underrepresented groups. The CEP will also encourage and support awardee presentations at national or international meetings. The ultimate deliverable of our CEP is to train and cultivate the highest caliber of next generation translational research scientists in GI cancers.

职业增强计划：摘要/摘要职业增强计划（CEP）的目标是开发训练有素，杰出的年轻人研究人员致力于胰腺的早期检测，预防和治疗中的翻译研究癌症（PDAC）和结直肠癌（CRC）。理想情况下，这些调查人员最终将有助于减少这些疾病的发病率和死亡率。 CEP将扩展在两个参与的情况下可用机构 - 安德森和约翰·霍普金斯大学，扩大了专业知识和心态的范围早期职业调查员可用的机会。强调我们计划的共同性质，CEP 将由博士领导。约翰·霍普金斯（Johns Hopkins）的伊丽莎白·贾菲（Elizabeth Jaffee）和医学博士安德森（MD Anderson）的斯科特·科佩兹（Scott Kopetz）。这 CEP将a）招募和培训医师和基本科学家，使他们能够成为高技能的翻译 PDAC或CRC领域的研究人员b）提供PDAC或CRC研究的具体知识增强获奖者进行创新转化科学的能力，这将直接影响了解和治疗这些疾病； 3）重新指导已经显示的个人 PDAC或CRC研究的科学承诺很大。为了实现这一目标，孢子CEP将提供每年最多五个奖项为50,000美元，一年，还有续约的竞争选择一年，由MD Anderson和Johns Hopkins的孢子和相匹配的资金资助。我们将积极进取招募最有前途的年轻调查员，并通过临床和实验室导师和指导委员会将提供赠款和手稿写作的教练，领导培训，与PDAC和CRC学者建立联系（包括同时发生的关键意见领导者全国各地资助的孢子计划），完成和发布转化PDAC或与CRC相关高影响同行评审期刊中的手稿。胃肠道孢子将在内部使用多个程序在研究所之外，确定杰出的年轻调查员，重点放在招聘合格的妇女和传统代表性不足的群体的成员。 CEP还将鼓励和支持在国家或国际会议上的获奖者演讲。我们CEP的最终交付是培训和培养GI癌中下一代转化研究科学家的最高水平。